Western University, Canada clinical trials
Western University, Canada is the lead sponsor of 39 current clinical trials in our Canada register. 19 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Semaglutide, Dalteparin and Denosumab. The most-studied condition is Functional Movement Disorder.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by Western University, Canada
39 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Creatine and Resistance Training in Older Adults With Mild Cognitive Impairment
NCT06948149 · ClinicalTrials.gov ↗ · Creatine, Exercise, Mild Cognitive Impairment (MCI)
|
Not applicable | Recruiting | 2026-01 | Canada |
|
Longitudinal Study of Xenon-129 MRI Imaging Effects of Cannabis Smoking
NCT03909477 · ClinicalTrials.gov ↗ · Cannabis Use, Cannabis Smoking, Marijuana Smoking
|
Observational | Recruiting | 2022-06 | Canada |
|
Caregiver Training to Support Children With Social Communication Challenges
NCT06909279 · ClinicalTrials.gov ↗ · Autism Spectrum Disorder, Suspected Autism, Social Communication Challenges
|
Not applicable | Recruiting | 2025-05 | Canada |
|
Confirming Permanent Lack of Blood Flow to the Brain During A-NRP DCC Organ Transplant
NCT05884736 · ClinicalTrials.gov ↗ · Organ Transplant
|
Observational | Recruiting | 2024-04 | Canada |
|
Needle Localization During Prostate Brachytherapy Using Power Doppler Ultrasound
NCT03861507 · ClinicalTrials.gov ↗ · Prostate Cancer
|
Not applicable | Recruiting | 2020-03 | Canada |
|
Novel Pulmonary Imaging of Lung Structure and Function in E-cigarette Smokers
NCT04616313 · ClinicalTrials.gov ↗ · E Cigarette Use
|
Observational | Recruiting | 2023-01 | Canada |
|
A Feasibility Randomized Trial Evaluating Early vs Late Stent Removal Following Radical Cystectomy and Ileal Conduit Formation for Bladder Cancer
NCT06595446 · ClinicalTrials.gov ↗ · Bladder Cancer Requiring Cystectomy, Ileal Conduit, Urinary Diversion
|
Not applicable | Recruiting | 2024-11 | Canada |
|
A Nutrition and Exercise Lifestyle Intervention Program Participant Choice Approach
NCT06187675 · ClinicalTrials.gov ↗ · Lifestyle, Healthy, Pregnancy Related, Adherence, Treatment
|
Not applicable | Recruiting | 2024-01 | Canada |
|
3DUS Imaging of Needles in Gynecological Brachytherapy
NCT04705467 · ClinicalTrials.gov ↗ · Gynecologic Cancer
|
Not applicable | Recruiting | 2022-10 | Canada |
|
Tech-wise Driver (Technology Acceptance of Targeted ADAS for Older Adults)
NCT06437665 · ClinicalTrials.gov ↗ · Older Adults, Driving, Simulator
|
Not applicable | Recruiting | 2025-02 | Canada |
|
Comorbidity Management in Rheumatic Disease.
NCT06579222 · ClinicalTrials.gov ↗ · Rheumatoid Arthritis, Comorbidities and Coexisting Conditions
|
Not applicable | Recruiting | 2025-05 | Canada |
|
(3D) Ultrasound Imaging Liver and Kidney
NCT03844399 · ClinicalTrials.gov ↗ · Liver Cancer, Kidney Cancer
|
Observational | Recruiting | 2020-10 | Canada |
|
Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2
NCT06396416 · ClinicalTrials.gov ↗ · Obesity, Chronic Kidney Disease
Drugs: Semaglutide, Wegovy |
Phase 4 | Recruiting | 2024-09 | Canada |
|
Evaluation of the Transitional and Lifelong Care Program
NCT05849285 · ClinicalTrials.gov ↗ · Cerebral Palsy, Spina Bifida, Developmental Disability
|
Observational | Recruiting | 2024-01 | Canada |
|
A Clinical Trial of Primary Retroperitoneal Lymph Node Dissection in Patients With Testicular Seminoma With Limited Retroperitoneal Metastases
NCT06932458 · ClinicalTrials.gov ↗ · Testicular Cancer
|
Phase 2 | Recruiting | 2025-07 | Canada |
|
Survivorship After HNC: A Randomized Controlled Trial Evaluating Patient Care and Adherence to Follow-up
NCT06127784 · ClinicalTrials.gov ↗ · Head and Neck Cancer, Survivorship
|
Not applicable | Recruiting | 2025-05 | Canada |
|
Breast 3DUS ABUS System Comparison
NCT06118996 · ClinicalTrials.gov ↗ · Breast Diseases
|
Not applicable | Recruiting | 2024-08 | Canada |
|
Domain-specific Aerobic Exercise Training in Coronary Artery Disease
NCT06143332 · ClinicalTrials.gov ↗ · Coronary Artery Disease
|
Not applicable | Recruiting | 2024-11 | Canada |
|
129-Xe MRI Study of Single Triple Therapy Inhaler Effects in COPD Patients With Moderate-severe Dyspnea and/or Poor Health Status With High or Low Risk of Exacerbation
NCT07192016 · ClinicalTrials.gov ↗ · Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | Recruiting | 2026-04 | Canada |
|
Passive Thoughts in Functional Movement Disorders
NCT06439017 · Functional Movement Disorder
|
Observational | Not yet open | 2025-03 | Canada |
|
Prolonged Hypercoagulability Following Major Liver Resection for Malignancy
NCT06153394 · ClinicalTrials.gov ↗ · Hepatic Disease, Surgery-Complications, Hypercoagulability
Drugs: Dalteparin, Fragmin |
Phase 3 | Not yet open | 2024-06 | Canada |
|
Study of Sensory Attenuation in Functional Movement Disorders
NCT06872788 · ClinicalTrials.gov ↗ · Functional Movement Disorder
|
Observational | Not yet open | 2025-09 | Canada |
|
Feasibility and Usability of a Mobile App for Monitoring and Managing Functional Movement Disorders
NCT07372755 · ClinicalTrials.gov ↗ · Functional Movement Disorder
|
Observational | Not yet open | 2026-02 | Canada |
|
Post-osteoporotic Fracture Exercise Program
NCT07595991 · ClinicalTrials.gov ↗ · Osteoporosis, Osteoporotic Fracture
|
Not applicable | Not yet open | 2026-09 | Canada |
|
Lipiodal Injection Technique for Free Flap Sparing Adjuvant RT Planning in HNC
NCT06806189 · ClinicalTrials.gov ↗ · Head and Neck Cancer
|
Early Phase 1 | Not yet open | 2025-04 | Canada |
|
Labral Repair vs Reconstruction
NCT07608237 · ClinicalTrials.gov ↗ · Femoral Acetabular Impingement
|
Not applicable | Not yet open | 2026-09 | Canada |
|
Handwriting Analysis in Movement Disorders.
NCT06436287 · ClinicalTrials.gov ↗ · Movement Disorders
|
Observational | Not yet open | 2025-01 | Canada |
|
Action Outcome Latencies as a Measure of Sense of Agency in Functional Movement Disorders.
NCT07302308 · ClinicalTrials.gov ↗ · Functional Movement Disorder
|
Observational | Not yet open | 2026-01 | Canada |
|
Enhancing Patient Comfort and Reducing Anxiety During Flexible Cystoscopy and Bladder Instillation in Bladder Cancer Patients: A Randomized Controlled Trial and Observational Study
NCT07204301 · ClinicalTrials.gov ↗ · Bladder Cancer
|
Not applicable | Not yet open | 2025-11 | Canada |
|
Venous Excess Ultrasound for Personalized Resuscitation in Septic Shock
NCT06696391 · ClinicalTrials.gov ↗ · Septic Shock, Sepsis, Shock
|
Phase 3 | Not yet open | 2024-12 | Canada |
|
Cognitive Cueing and Video Intervention for Gait in Parkinson's Disease
NCT06894030 · ClinicalTrials.gov ↗ · Parkinson's Disease
|
Not applicable | Not yet open | 2025-04 | Canada |
|
REverse LuNg Airway and Vascular RemOdeling in Asthma ReMission (ReNORM)
NCT07174713 · ClinicalTrials.gov ↗ · Asthma; Eosinophilic
|
Not applicable | Not yet open | 2026-10 | Canada |
|
Exercise and Diabetes Interventions to Improve Brain Health in Older Adults With Type 2 Diabetes
NCT07485062 · ClinicalTrials.gov ↗ · Type 2 Diabetes, Cognitive Decline in Older Adults
Drug: Semaglutide |
Phase 4 | Not yet open | 2026-09 | Canada |
|
Long-term Follow up of the Stability 1 Trial
NCT06885372 · ClinicalTrials.gov ↗ · LET, ACL Reconstruction, Osteoarthritis (OA) of the Knee
|
Not applicable | By invitation | 2024-11 | Canada |
|
The FreeStyle Libre Enabled Reduction of A1c Through Effective Eating and Exercise Study
NCT05261906 · ClinicalTrials.gov ↗ · Diabetes Mellitus, Type 2
|
Not applicable | Active, closed | 2022-09 | Canada |
|
PRevEnting FracturEs in REnal Disease - 1
NCT05096195 · ClinicalTrials.gov ↗ · Kidney Diseases, Dialysis; Complications, Fragility Fracture
|
Phase 4 | Active, closed | 2022-06 | Canada |
|
Remplissage Versus Latarjet Coracoid Transfer for Recurrent Shoulder Instability
NCT03453710 · ClinicalTrials.gov ↗ · Shoulder Dislocation
|
Not applicable | Active, closed | 2018-10 | Canada |
|
Lung Structure-Function In Survivors of Mild and Severe COVID-19 Infection
NCT04584671 · ClinicalTrials.gov ↗ · Covid19
|
Observational | Active, closed | 2021-01 | Canada |
|
STABILITY: Physical Activity Intervention at 7 Years Post-Anterior Cruciate Ligament Reconstruction
NCT05152758 · ClinicalTrials.gov ↗ · Anterior Cruciate Ligament Reconstruction, Post-traumatic Osteoarthritis
|
Not applicable | Active, closed | 2021-11 | Canada |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Drugs in Western University, Canada trials
6 compoundsDrugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.
Conditions in Western University, Canada trials
69 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Canada | 39 | 19 |
A trial with sites in more than one country appears in each of those registers.
Questions about Western University, Canada trials
How many clinical trials does Western University, Canada sponsor?
Western University, Canada is the lead sponsor of 39 current trials on ClinicalTrials.gov in our Canada register, as of the registry sync on 12 November 2026. Completed and withdrawn studies are not counted.
Are Western University, Canada trials recruiting?
Yes. 19 of its 39 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Which drugs is Western University, Canada testing?
Its current trials name 6 drugs and biologicals as interventions. The most frequent are Semaglutide (2), Dalteparin (1), Denosumab (1), Fragmin (1) and Prolia (1). The number in brackets is how many of its trials name each drug.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 12 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.